Results 151 to 160 of about 9,856 (174)

CANCER THERAPY TARGETING NKG2A

2023
ANDERSEN DANIEL, LAUGEL BRUNO, MELANDER EVA MARIA CARLSEN, NANCY-PORTEBOIS VANESSA, OCANA FERNANDEZ ALBERTO, PIERRAT MARIE-JEANNE, UHLENBROCK FRANZISKA KATHARINA   +6 more
openaire   +1 more source

SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells

Cell Reports, 2022
Kimia Maleki, Myriam Aouadi, Jakob Michaelsson   +2 more
exaly  

NKG2A-TARGETING ANTIBODY AND USE THEREOF

2022
ZHOU YALI, CHEN GONG, JIANG XIAOYAN, GUO TINGTING, REN JIANGTAO, HE XIAOHONG, WANG YANBIN, HAN LU   +7 more
openaire   +2 more sources

Increased NKG2A+CD8+ T-cell exhaustion in adenomyosis

Journal of Reproductive Immunology, 2023
Wei Liu, Shuman Sheng, Chendi Zhu, Changzhong Li, Yonghui Zou, Chunrun Yang, Zi-Jiang Chen, Fei Wang, Xue Jiao   +8 more
openaire   +1 more source

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines

Cell, 2018
Young Kim, Pornpimol Charoentong, Linda Borst   +2 more
exaly  

The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8+ T Cells in Response to a Lethal Poxvirus Infection

Immunity, 2015
Marco Colonna, Hanspeter Pircher, Marina Cella   +2 more
exaly  

Monoclonal antibodies against NKG2A

2006
MORETTA ALLESSANDRO, MARCENARO EMANUELA, ROMAGNE FRANCOIS, ANDRE PASCALE   +3 more
openaire   +12 more sources

ANTI-NKG2A ANTIBODIES AND USES THEREOF

2008
SPEE PIETER, PADKJÆR SØREN BERG
openaire   +9 more sources

High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer

OncoImmunology, 2017
Rui Sun, Hao Wen, Weihua Xiao
exaly  

Humanized anti-human NKG2A monoclonal antibody

2009
SPEE PETRUS JOHANNES LOUIS, CHEN JIANHE, PADKJAER SOEREN BERG, JING SU, ZHANG JINCHAO, YU JIUJIU   +5 more
openaire   +7 more sources